JW Lifescience Corporation (234080.KS) KSC
11,250.00
+110(+0.99%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
11,250.00
+110(+0.99%)
Currency In KRW
Address
28, Hanjin 1-gil
Dangjin-si, 343-823
Korea (the Republic of)
Phone
82 4 1351 7600
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
301
First IPO Date
October 27, 2016
| Name | Title | Pay | Year Born |
| Sungnam Cha | Chief Executive Officer & Director | 0 | N/A |
| Jeong Yeol Noh | Executive Director & Head of HP Research Center | 0 | N/A |
| Na Sook Hee | Executive Director | 0 | N/A |
JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin, South Korea.